Toll-like receptor 4 deficiency ameliorates β2-microglobulin induced age-related cognition decline due to

Qi Zhong1, Yufeng Zou1, Hongchao Liu1,2

  • 1Department of Anesthesiology, Zhongnan Hospital, Wuhan University, East Lake Road, Wuhan, 430071, Hubei, China.

Molecular Brain
|February 16, 2020
PubMed

Insights

Toll-like receptor 4 (TLR4) exacerbates cognitive decline caused by β2-microglobulin (B2M) through neuroinflammation and apoptosis. Blocking TLR4 may offer a neuroprotective strategy against age-related cognitive impairment.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • β2-microglobulin (B2M) is implicated in age-related cognitive decline.
  • Toll-like receptor 4 (TLR4) plays a role in neuroinflammation and neuronal apoptosis.

Purpose of the Study:

  • To investigate the role of TLR4 in B2M-induced age-related cognitive decline.
  • To explore the underlying mechanisms involving neuroinflammation, apoptosis, and synaptic function.

Main Methods:

  • Utilized wild-type and TLR4 knockout mice, treated with B2M or vehicle.
  • Assessed cognitive function using the Morris Water Maze.
  • Analyzed hippocampal neurogenesis, neuronal damage, inflammation, apoptosis, synaptic proteins, and the TLR4/MyD88/NF-κB pathway.

Main Results:

  • B2M induced cognitive decline, neuroinflammation, and apoptosis in wild-type mice, effects attenuated in TLR4 knockout mice.
  • TLR4 deletion improved hippocampal neurogenesis and synaptic protein levels after B2M treatment.
  • Cell experiments confirmed TLR4's role in B2M-induced neuroinflammation, apoptosis, and pathway regulation.

Conclusions:

  • TLR4 contributes to B2M-induced age-related cognitive decline via neuroinflammation and apoptosis.
  • The TLR4/MyD88/NF-κB pathway mediates these effects by modulating hippocampal neurogenesis and synaptic function.
  • Targeting TLR4 presents a potential neuroprotective strategy for age-related cognitive impairment.

Related Concept Videos